FORA Capital LLC Takes $984,000 Position in The Cooper Companies, Inc. $COO

Key Points

• FORA Capital LLC invested approximately $984,000 in The Cooper Companies, purchasing 11,663 shares during the first quarter of 2023.
• Multiple hedge funds, including JPMorgan Chase and Goldman Sachs, have recently increased their stakes in The Cooper Companies, highlighting growing institutional interest.
• Analysts have mixed ratings on the stock, with revisions ranging from "buy" to "hold," and an average price target set at $96.73.

FORA Capital LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 11,663 shares of the medical device company's stock, valued at approximately $984,000.

Other institutional investors have also modified their holdings of the company. Zions Bancorporation National Association UT acquired a new stake in shares of Cooper Companies in the first quarter valued at about $33,000. City Holding Co. acquired a new stake in shares of Cooper Companies in the first quarter valued at about $34,000. GKV Capital Management Co. Inc. acquired a new stake in shares of Cooper Companies in the first quarter valued at about $40,000. Larson Financial Group LLC boosted its position in Cooper Companies by 1,071.0% during the first quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after acquiring an additional 664 shares during the last quarter. Finally, HM Payson & Co. boosted its position in Cooper Companies by 147.4% during the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after acquiring an additional 532 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on COO. Loop Capital set a $100.00 price target on shares of Cooper Companies in a research report on Tuesday, June 17th. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $90.00 to $85.00 and set a "buy" rating on the stock in a research report on Thursday, August 28th. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, July 22nd. Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the stock an "equal weight" rating in a research report on Thursday. Finally, Robert W. Baird lowered their price target on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating on the stock in a research report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $86.64.

Cooper Companies Trading Down 2.5%

Shares of Cooper Companies stock traded down $1.72 on Tuesday, reaching $65.68. The company had a trading volume of 659,947 shares, compared to its average volume of 2,256,943. The firm's 50 day moving average price is $72.25 and its two-hundred day moving average price is $77.14. The firm has a market cap of $13.06 billion, a PE ratio of 32.35, a PEG ratio of 1.63 and a beta of 0.97. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.